3 completed. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
Follow Vireo Systems, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Objective of This Study Was to Compare and Quantify the Bioavailability of Citrulline Byproducts in Blood Samples and in Urine Samples After a Single Dose of the Assigned Dietary Supplement. The Treatment Arms Containing the Following Molecules: Citrulline HCL and L-Citrulline, Removal from study. In case of adverse event, subject treated for the AE., removal from study - Bioavailability and AUC | Completed | Vireo Systems, Inc. | 32 | 2024-07-13 | 2025-05-18 | |
| Gastrointestinal and Fluid Retention Symptoms Associated With Creatine Monohydrate With and Without Loading Dose Over 28 Days of Supplementation Creatine Monohydrate - Side Effects of Creatine Monohydrate Dosing | Completed | Vireo Systems, Inc. | 24 | 2024-05-30 | 2025-09-16 | |
| Short-Term Safety of Low-Dose Creatine Hydrochloride: A 28-Day Single-Arm Pilot Study creatine supplementation - Safety of Short Term Creatine Hydrochloride Dosing | Not applicable | Completed | Vireo Systems, Inc. | 11 | 2024-05-30 | 2026-04-09 |
Creatine (2)
United States (3)